Published in Clin Auton Res on October 01, 2003
Central Sympathetic Activation and Arrhythmogenesis during Acute Myocardial Infarction: Modulating Effects of Endothelin-B Receptors. Front Cardiovasc Med (2015) 0.81
Cardiac neural discharge preceding sudden death: efferent, afferent or both? Clin Auton Res (2003) 0.75
Sponsorship, authorship, and accountability. Lancet (2001) 7.10
Sponsorship, authorship, and accountability. N Engl J Med (2001) 6.20
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet (2000) 6.01
Sponsorship, authorship and accountability. CMAJ (2001) 5.86
Tackling the wider social determinants of health and health inequalities: evidence from systematic reviews. J Epidemiol Community Health (2009) 2.90
Unsatisfactory redefinition of myocardial infarction. Lancet (2001) 2.89
Population tobacco control interventions and their effects on social inequalities in smoking: systematic review. Tob Control (2008) 2.76
The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril (1987) 2.62
Aldosterone and its regulation during diuresis in patients with gross congestive heart failure. Clin Sci Mol Med (1974) 2.60
Resource allocation to health authorities: the quest for an equitable formula in Britain and Sweden. BMJ (1997) 2.51
Management of raised blood pressure in New Zealand. N Z Med J (1993) 2.48
The Elag-Koln automatic blood pressure recorder. A clinical appraisal. Br Heart J (1977) 2.34
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation (1998) 2.17
Management of raised blood pressure. N Z Med J (1994) 2.03
Reviewing evidence on complex social interventions: appraising implementation in systematic reviews of the health effects of organisational-level workplace interventions. J Epidemiol Community Health (2008) 2.00
Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet (1985) 1.95
Real-time ultrasonography for determination of ovarian morphology and volume. A possible early screening test for ovarian cancer? Lancet (1982) 1.82
Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol (1977) 1.77
Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) (1997) 1.73
Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese. Stroke (1991) 1.61
Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure. Br Heart J (1976) 1.59
Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study. J Hum Hypertens (1989) 1.55
A randomised comparison of SurePath liquid-based cytology and conventional smear cytology in a colposcopy clinic setting. BJOG (2008) 1.55
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol (2001) 1.54
Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res (1997) 1.54
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Cough with angiotensin converting-enzyme inhibitors. N Z Med J (1987) 1.48
Lone mothers in Sweden: trends in health and socioeconomic circumstances, 1979-1995. J Epidemiol Community Health (1999) 1.48
Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension. Lancet (1984) 1.48
Clearance of chronic psoriasis after eradication therapy for Helicobacter pylori infection. J Eur Acad Dermatol Venereol (2007) 1.47
Hypertension--still an important cause of heart failure? J Hum Hypertens (2005) 1.46
Polypharmacy--we make it worse! A cross-sectional study from an acute admissions unit. Intern Med J (2012) 1.44
Current patterns and trends in male mortality by social class (based on occupation). Popul Trends (1996) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
The management of mildly raised blood pressure in New Zealand: an alternative view. N Z Med J (1996) 1.42
Pressure-limited ventilation with permissive hypercapnia and minimum PEEP in saline-lavaged rabbits allows progressive improvement in oxygenation, but does not avoid ventilator-induced lung injury. Intensive Care Med (1996) 1.41
Oestrogens for menopausal flushing. Br Med J (1977) 1.40
Imperial Cancer Research Fund and the Lancet. Lancet (1997) 1.39
Calorie-restricted weight reduction, blood pressure, and atrial natriuretic peptides. Nutrition (1993) 1.38
Sulindac and cough induced by converting enzyme inhibitors. Lancet (1987) 1.38
Treatment of severe orthostatic hypotension with the somatostatin analogue octreotide. Aust N Z J Med (1990) 1.37
Mortality in regions and local authority districts in the 1990s: exploring the relationship with deprivation. Popul Trends (1995) 1.37
The health and socio-economic circumstances of British lone mothers over the last two decades. Popul Trends (1999) 1.33
The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun (1995) 1.33
Inequality in the social consequences of illness: how well do people with long-term illness fare in the British and Swedish labor markets? Int J Health Serv (2000) 1.30
The social and economic consequences of childhood-onset Type 1 diabetes mellitus across the lifecourse: a systematic review. Diabet Med (2006) 1.30
Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab (1994) 1.29
Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure. Lancet (1981) 1.26
The social and economic consequences of childhood asthma across the lifecourse: a systematic review. Child Care Health Dev (2004) 1.25
Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas (1986) 1.24
Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies. Am J Cardiol (1982) 1.22
Sponsorship, authorship, and accountability. JAMA (2001) 1.22
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
Hyponatremic-hypertensive syndrome with renal ischemia: an underrecognized disorder. Hypertension (1999) 1.20
Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood (1990) 1.20
Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J (1993) 1.19
Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease. Br Heart J (1985) 1.18
Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol (1985) 1.18
Haemodynamic effects of atrial peptide infusion in heart failure. Lancet (1986) 1.16
Interrelations of calcium-regulating hormones during normal pregnancy. Br Med J (Clin Res Ed) (1981) 1.16
Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. BMJ (1992) 1.15
Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J Clin Endocrinol Metab (1986) 1.14
Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab (2007) 1.13
"A hard day's night?" The effects of Compressed Working Week interventions on the health and work-life balance of shift workers: a systematic review. J Epidemiol Community Health (2008) 1.12
Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible? Fertil Steril (2000) 1.12
Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. Circulation (1999) 1.12
Tackling inequalities in health: evaluating the New Deal for Communities initiative. J Epidemiol Community Health (2008) 1.12
Natriuretic hormones. Endocrinol Metab Clin North Am (1995) 1.12
High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol (1995) 1.11
The haemodynamic, histopathological and hormonal features of alcoholic cardiac beriberi. Q J Med (1981) 1.10
The role of income differences in explaining social inequalities in self rated health in Sweden and Britain. J Epidemiol Community Health (2001) 1.10
Stroke subtypes among Chinese living in Hong Kong: the Shatin Stroke Registry. Neurology (1992) 1.09
Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clin Sci (Lond) (1980) 1.09
Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure. Br Heart J (1983) 1.07
New government, same narrow vision. Health authorities in New Zealand have spin doctors to produce good news. BMJ (1998) 1.07
Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. Kidney Int (2000) 1.06
Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. Life Sci (1986) 1.06
The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol (1990) 1.05
Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure. Aust N Z J Med (1986) 1.05
Rapid onset of blindness due to meningeal carcinomatosis from an oesophageal adenocarcinoma. Postgrad Med J (1991) 1.05
Does sodium hyaluronate- and carboxymethylcellulose-based bioresorbable membrane (Seprafilm) decrease operative time for loop ileostomy closure? Tech Coloproctol (2006) 1.04
Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension. Br Heart J (1982) 1.04
Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet (1991) 1.03
Cardiac secretion of atrial natriuretic peptide. Lancet (1985) 1.03
Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group. Heart (1999) 1.01
Brain stem stroke causing baroreflex failure and paroxysmal hypertension. Stroke (2000) 1.00
Delayed pulmonary hypertension following splenectomy for congenital spherocytosis. Intern Med J (2004) 1.00
Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochem Biophys Res Commun (2001) 0.99
Working for health? Evidence from systematic reviews on the effects on health and health inequalities of organisational changes to the psychosocial work environment. Prev Med (2008) 0.99
Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin Exp Hypertens A (1986) 0.99
Continuous recording of pulmonary artery pressure in unrestricted subjects. Br Heart J (1984) 0.99
Cloning and characterization of a novel polygalacturonase-encoding gene from Aspergillus parasiticus. Gene (1995) 0.97
Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin Chem (1998) 0.97
Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model. J Physiol (2005) 0.96
Measurement of form-factor-independent observables in the decay B0→K(*0)μ(+)μ(-). Phys Rev Lett (2013) 0.96
Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation (1997) 0.96
Hyponatraemia in congestive heart failure during treatment with captopril. Br Med J (1980) 0.96
Respiratory failure secondary to diabetic neuropathy affecting the phrenic nerve. Diabet Med (2003) 0.96